SurfON is trying to find out how best to treat babies born two to six weeks early with breathing problems.
SurfON Recruitment - COVID 19 Update
Following the pause to the launch of SurfON, we are pleased to announce that the SurfON trial is now open to recruitment. We are currently working with NHS Trusts individually in order to assess capacity and capability for the commencement of recruitment to SurfON. Please email firstname.lastname@example.org if you have any queries.
SurfON is a multicentre, open-label, randomised controlled trial of early surfactant therapy versus expectant management in late preterm and early term infants with respiratory distress. The study is run by the National Perinatal Epidemiology Unit Clinical Trials Unit (NPEU CTU) at the University of Oxford. The study is funded by the National Institute of Health Research (NIHR) [Health Technology Assessment (HTA) programme (Project reference 17/89/07) and sponsored by the University of Leicester.